Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 9,290,493
App. No.: 14/552,108
Granted: Mar 22, 2016
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention is related to novel compounds of formula (I) that inhibit the activity of the FabI enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.

Claims (4)

1. A compound selected from the group consisting of:

and pharmaceutically acceptable salts thereof.

2. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and an effective amount of a compound selected from the group consisting of:

and pharmaceutically acceptable salts thereof.

Assignments (11)

CHANGE OF NAME Recorded Mar 6, 2019

From: JANSSEN SCIENCES IRELAND UC

To: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

Reel/Frame 048523/0408 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018

From: KOUL, ANIL

To: JANSSEN PHARMACEUTICA NV

Reel/Frame 046576/0468 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018

From: BALEMANS, WENDY MIA ALBERT